Embattled Masimo Corp. founder Joe Kiani, who was ousted as chairman, resigned as chief executive last week—making good on ...

Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit. Kiani resigned after losing his board seat ...

In that way, Apple Watch owners would get not just one benefit, but two. They’d get back the blood oxygen measurement, but also have any hospital tests involving Masimo kit integrated into their Apple ...

It looks like Apple could be about to make a renewed push into the smart home market, with two new ‘homeOS’ devices ...

The longtime CEO of Masimo, Joe Kiani, has resigned from the company in the last few days and “that could open the door for ...

In what could become a new twist in the ongoing patent dispute over the Apple Watch’s Blood Oxygen sensor, the CEO of Masimo, ...

Just a week after being unseated from his position as the board’s chairman, Masimo’s founder has resigned from his position ...

Masimo CEO Joe Kiani may have waged and won a patent dispute against Apple over its blood oxygen sensor, he has stepped down ...

Wells Fargo analyst Vik Chopra maintained a Buy rating on Masimo (MASI – Research Report) yesterday and set a price target of $160.00.

Former Masimo CEO Joe Kiani may have won the war against Apple, but he has resigned after losing a fight with a hedge fund.

Masimo CEO Joe Kiani stepped down following a two-year skirmish with an activist investor that ejected him from his own board ...

Medical tech company Masimo ( MASI) had some significant C-suite news to report on Wednesday, and investors clearly welcomed ...